RT EU Medicines Agency
EMA’s #safety committee, the #PRAC, is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with GLP-1 receptor agonists used for weight loss and for treating type 2 #diabetes.
Read more in the news announcement: https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists https://t.co/Rf3Ly9FGbM

🐦🔗: https://n.respublicae.eu/EMA_News/status/1678794781256761346